March 23 (Reuters) – Evelo Biosciences Inc:

* CO AND ABDUL LATIF JAMEEL HEALTH ENTERED INTO A STRATEGIC COLLABORATION

* EVELO BIOSCIENCES-STRATEGIC COLLABORATION TO DEVELOP AND COMMERCIALIZE CO’S LEAD INFLAMMATION PRODUCT CANDIDATE EDP1815 IN MIDDLE EAST, TURKEY, AFRICA Source text for Eikon: Further company coverage:

(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html